{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-085244","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2022-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.243597+00:00","generated_at":"2026-06-26T17:23:02.581527+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"REGENXBIO settles Penn sublicense fees with $8M payment and $12M over 4 years; future fees removed","bullets":["Company pays $8.0M to Penn for sublicense fees related to AbbVie collaboration agreement.","Company will pay $12.0M over four years ($3M annually) to satisfy past/future sublicense obligations.","Letter agreement deletes Section 3.5 of Penn-REGENXBIO License, removing obligation to pay future sublicense fees.","Penn gains right to conduct gene therapy research outside a single identified field, with no restriction.","Parties agree to explore further expansion of relationship, including new collaboration and alliance opportunities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-085244","json":"https://secwatch.observer/filing/0001193125-22-085244.json","markdown":"https://secwatch.observer/filing/0001193125-22-085244.md","text":"https://secwatch.observer/filing/0001193125-22-085244.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000119312522085244/0001193125-22-085244-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000119312522085244/d330891d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T17:23:02.581527+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}